Trial Profile
Duloxetine in the treatment of melancholic depression: an 8-week open-label dose study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2005
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 05 Nov 2005 New trial record.